Oct 10, 2025 20:41
CRNX - Crinetics Pharmaceuticals, Inc.
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
44.97 -0.83 (-1.85%) | --- | --- | --- | 0.53 (1.18%) | -0.1 (-0.23%) | --- | 0.53 (1.18%) |
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.
Category:
PHARMACEUTICAL PREPARATIONS
Market Period:
AfterHours
Earnings & Ratios
- Basic EPS:
- -1.23
- Diluted EPS:
- -1.23
- Basic P/E:
- -35.8862
- Diluted P/E:
- -35.8862
- RSI(14) 1m:
- 33.33
- VWAP:
- 44.15
- RVol:
- 0.4003
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 45.75 +0.78 (+1.73%) | Oct 15 08:29 |
Related News
Sep 28, 2025 12:30
Sep 26, 2025 14:23
Sep 26, 2025 12:10
Jul 13, 2025 21:45
May 23, 2025 12:00
Feb 06, 2025 21:35
Jan 10, 2025 12:00
Jan 09, 2025 18:00
Dec 16, 2024 14:10